Completed PHASE2 INTERVENTIONAL NCT00000188

Selegiline in Treatment of Cocaine Dependence - 2

Selegiline in Treatment of Cocaine Dependence

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Selegiline

Updated 5 times since 2017 Last updated: May 26, 2015 Started: Sep 30, 1994 Primary completion: Oct 31, 1995 Completion: Oct 31, 1995

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000188, this PHASE2 trial focuses on Cocaine-Related Disorders and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 5 times since 1994, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States